HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S J Hunter Selected Research

Pituitary Irradiation

10/2009Long term effect of external pituitary irradiation on IGF1 levels in patients with acromegaly free of adjunctive treatment.
1/2004Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S J Hunter Research Topics

Disease

5Insulin Resistance
01/2016 - 06/2000
5Hypertension (High Blood Pressure)
10/2014 - 05/2008
3Type 2 Diabetes Mellitus (MODY)
01/2016 - 06/2000
2Cardiovascular Diseases (Cardiovascular Disease)
01/2016 - 09/2013
2Hyperaldosteronism (Conn Syndrome)
10/2014 - 01/2012
2Essential Hypertension
10/2014 - 06/2000
2Diabetic Nephropathies (Diabetic Nephropathy)
12/2010 - 05/2010
2Acromegaly
10/2009 - 01/2004
1Pituitary Neoplasms (Pituitary Adenoma)
01/2015
1Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance)
01/2015
1Body Weight (Weight, Body)
09/2013
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2013
1Overweight
09/2013
1Hypertriglyceridemic Waist
09/2013
1Cushing Syndrome
01/2013
1Cardiogenic Shock
01/2013
1Hypertensive Crisis
01/2013
1Prolactinoma (Prolactinomas)
06/2012
1Residual Neoplasm
06/2012
1Adenoma (Adenomas)
01/2012
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2012
1Chronic Renal Insufficiency
05/2010
1Thyroid Neoplasms (Thyroid Cancer)
07/2008
1Trichinellosis
02/2008
1Infections
02/2008
1Hyperprolactinemia
01/2007
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2001
1Hemorrhage
12/2000
1Heart Failure
07/2000

Drug/Important Bio-Agent (IBA)

4Insulin (Novolin)FDA Link
10/2014 - 06/2000
3CreatinineIBA
01/2013 - 12/2010
3Hydrocortisone (Cortisol)FDA LinkGeneric
01/2013 - 05/2010
2Octreotide (Sandostatin)FDA LinkGeneric
01/2015 - 01/2004
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2015 - 01/2004
2Glucose (Dextrose)FDA LinkGeneric
10/2014 - 06/2000
125-hydroxyvitamin DIBA
01/2016
1AntibodiesIBA
01/2015
1Triiodothyronine (Liothyronine)FDA LinkGeneric
01/2015
1Eplerenone (Inspra)FDA LinkGeneric
10/2014
1Doxazosin (Cardura)FDA LinkGeneric
10/2014
1Biomarkers (Surrogate Marker)IBA
09/2013
1Protein Isoforms (Isoforms)IBA
09/2013
1AdiponectinIBA
09/2013
1CatecholaminesIBA
01/2013
1ProlactinIBA
06/2012
1PotassiumIBA
01/2012
1AldosteroneIBA
01/2012
1AlbuminsIBA
12/2010
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
05/2010
1Thyroid HormonesIBA
07/2008
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2008
1Bendroflumethiazide (Naturetin)FDA LinkGeneric
05/2008
1Captopril (Capoten)FDA LinkGeneric
05/2008
1Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA
05/2008
1ThiazidesIBA
05/2008
1antineoplaston A10 (A 10)IBA
02/2008
1Dopamine Agonists (Dopamine Agonist)IBA
01/2007
1Pharmaceutical PreparationsIBA
01/2004
1Growth Hormone (Somatotropin)IBA
01/2004
1Serotonin (5 Hydroxytryptamine)IBA
12/2000
1Adenosine Triphosphate (ATP)IBA
12/2000
1Endothelin-1 (Endothelin 1)IBA
07/2000
1Neuropeptide YIBA
07/2000
1Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
07/2000
1Calcitonin Gene-Related PeptideIBA
07/2000

Therapy/Procedure

4Therapeutics
01/2015 - 07/2008
2Pituitary Irradiation
10/2009 - 01/2004
1Operative Surgical Procedures
01/2013
1Adrenalectomy
01/2012
1Renal Replacement Therapy (Therapies, Renal Replacement)
05/2010
1Ambulatory Care (Outpatient Care)
05/2010